Extracellular Mitochondria Transfer in Gray and White Matter for Ameliorating Sensorimotor and Cognitive Deficits After Stroke
灰质和白质中的细胞外线粒体转移可改善中风后的感觉运动和认知缺陷
基本信息
- 批准号:10571863
- 负责人:
- 金额:$ 50.3万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-02-15 至 2027-01-31
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAgingAllograftingAnimalsAstrocytesBlood - brain barrier anatomyBlood VesselsBrainCRISPR/Cas technologyCell SurvivalCellsCentral Nervous SystemCerebral IschemiaCognitiveCognitive deficitsCollaborationsConfocal MicroscopyCyclic ADP-RiboseDataDementiaElectrophysiology (science)ElementsEndothelial CellsEndotheliumEnergy SupplyEtiologyFemaleGlucoseGolgi ApparatusHomeostasisHumanIn VitroInfarctionIntegrinsIschemiaKnowledgeLabelMammalian CellMapsMass Spectrum AnalysisMediatingMetabolismMethodsMitochondriaMitochondrial ProteinsModificationMolecularMusNeurologicNeuronal PlasticityNeuronsOligodendrogliaOligonucleotidesOutcomeOxygenPARK7 genePECAM1 genePathway interactionsPatternPlasmidsPlayPost-Translational Protein ProcessingProcessPropertyProteinsPublishingRattusRecombinantsRecoveryRecovery of FunctionRoleSensorimotor functionsSignal InductionSignal PathwaySignal TransductionSite-Directed MutagenesisSmall Interfering RNASpecific qualifier valueStrokeTestingTherapeuticTissuesWestern Blottingangiogenesisbehavioral outcomebrain endothelial cellcognitive functioncognitive recoverycognitive testingdeprivationexperimental studyextracellularfunctional improvementgain of functionglycationgray matterimprovedin vivoin vivo imaginginhibitorloss of functionmaleneural growthneurogenesisneurological recoveryneuroprotectionneurovascularneutralizing antibodynovelnovel strategiesnovel therapeutic interventionoligodendrocyte precursoroptical imagingpharmacologicpost strokepost stroke dementiapotential biomarkerprecursor cellpreventremyelinationrepairedresponsesingle nucleus RNA-sequencingspatiotemporaltooltraffickingtranscriptomewhite matter
项目摘要
Extracellular mitochondria transfer in gray and white matter for ameliorating sensorimotor and
cognitive deficits after stroke
Mitochondrial function is essential for maintaining cellular homeostasis in the central nervous system (CNS). It
is now recognized that mitochondria are surprisingly released and transferred between cells. However, the
underlying mechanisms remain poorly understood. In this proposal, we will investigate post-translational
modification by O-GlcNAc as a critical element for extracellular mitochondrial functionality and the transfer-
mediated blood-brain barrier recovery, oligodendrocyte protection and neural plasticity after stroke.
Our pilot data suggest that (i) ER-Golgi trafficking may regulate mitochondrial protein O-GlcNAcylation, (ii)
transfer of O-GlcNAcylated mitochondria may protect neurons, oligodendrocyte precursors and endothelial
cells against oxygen-glucose deprivation, (iii) blockade of DJ1 O-GlcNAcylation may increase mitochondrial
glycation and degradation, thus reducing the protective capacity of extracellular mitochondria, (iv) levels of
mitochondrial O-GlcNAc-DJ1 may be positively correlated with functional recovery after stroke and negatively
correlated with aging, (v) methods to dissect these mechanisms (molecular tools, optical imaging,
electrophysiology, snRNA-seq etc) are feasible in our collaborating labs.
Based on our pilot data, we hypothesize that damage associated molecular pattern (DAMP) or CD31 signals
upregulate CD38 in reactive astrocytes, and CD38-driven post-translational modification by O-GlcNAc supports
extracellular mitochondrial functionality that accelerates viable mitochondrial transfer-mediated neurovascular
remodeling and remyelination, thus ameliorating sensorimotor deficits and post-stroke dementia after stroke.
We have 3 specific aims. In Aim 1, we will dissect mechanisms of O-GlcNAc-modified mitochondrial release
and transfer between astrocytes and neurons or brain endothelial cells or OPCs/oligodendrocytes. In Aim 2,
we will investigate O-GlcNAcylated mitochondrial transfer in gray matter and white matter in young, older, male
or female mice after focal ischemia. In Aim 3, we will use gain- and loss-of-function experiments to modify
mitochondrial protein O-GlcNAcylation, and assess sensorimotor and cognitive outcomes in vivo. Our
experiments will utilize molecular tools including a combination of pharmacologic activators/inhibitors, site-
directed mutagenesis, and AAV-induced mitochondrial labeling to assess astrocyte-specific mitochondria
transfer. Single-nuclei RNA seq will be performed to fully map transcriptomes in gray and white matter post-
stroke. Translational relevance will be assessed with in vivo imaging, electrophysiology and long-term
outcomes post-stroke. This project should define a novel mechanism of mitochondrial transfer in both gray and
white matter, and hopefully provide new approaches to accelerate sensorimotor recovery and ameliorate post-
stroke vascular-related dementia.
细胞外线粒体在灰色和白质中转移,以改善感觉运动和
中风后认知缺陷
线粒体功能对于维持中枢神经系统(CNS)中的细胞稳态至关重要。它
现在认识到线粒体在细胞之间出奇地释放并转移。但是,
潜在的机制仍然很少理解。在此提案中,我们将调查翻译后
O-GLCNAC修饰是细胞外线粒体功能和转移 - 的关键元素
中风后介导的血脑屏障恢复,少突胶质细胞保护和神经可塑性。
我们的试点数据表明,(i)er-golgi运输可能调节线粒体蛋白O-glcnacylation,(ii)
O-Glcnacylated线粒体的转移可能保护神经元,少突胶质前体和内皮
抗氧葡萄糖剥夺的细胞,(iii)DJ1 O-Glcnacylation的阻断可能会增加线粒体
糖基化和降解,从而降低了细胞外线粒体的保护能力,(iv)水平
线粒体O-GLCNAC-DJ1可能与中风后的功能恢复正相关,并负面相关
与衰老相关,(v)剖析这些机制的方法(分子工具,光学成像,
在我们的协作实验室中,电生理学,SNRNA-SEQ等是可行的。
根据我们的试点数据,我们假设损害相关的分子模式(潮湿)或CD31信号
在反应性星形胶质细胞中上调CD38,以及通过O-GLCNAC支持的CD38驱动的翻译后修饰
细胞外线粒体功能,可加速可行的线粒体转移介导的神经血管
重塑和再髓式,从而改善了中风后的感觉运动缺陷和中风后痴呆症。
我们有3个具体目标。在AIM 1中,我们将剖析O-GlCNAC修饰的线粒体释放的机制
以及星形胶质细胞和神经元或脑内皮细胞或OPC/少突胶质细胞之间的转移。在AIM 2中,
我们将研究灰质的O-GlcnacyLated线粒体转移,年轻,年龄较大,男性
局灶性缺血后的雌性小鼠。在AIM 3中,我们将使用功能丧失实验来修改
线粒体蛋白O-Glcnacylation,并在体内评估感觉运动和认知结果。我们的
实验将利用分子工具,包括药理学激活剂/抑制剂,部位 -
定向诱变和AAV诱导的线粒体标记,以评估星形胶质细胞特异性线粒体
转移。将进行单核RNA SEQ,以完全绘制灰色和白质的转录组 -
中风。翻译相关性将通过体内成像,电生理和长期评估
结果后的结果。该项目应定义灰色和灰色和线粒体转移的新机制
白质,希望提供新的方法来加速感觉运动恢复并改善后
中风血管相关痴呆。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kazuhide Hayakawa其他文献
Kazuhide Hayakawa的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kazuhide Hayakawa', 18)}}的其他基金
Extracellular mitochondria transfer in gray and white matter for ameliorating sensorimotor and cognitive deficits after stroke
灰质和白质中的细胞外线粒体转移可改善中风后的感觉运动和认知缺陷
- 批准号:
10415616 - 财政年份:2022
- 资助金额:
$ 50.3万 - 项目类别:
Meningeal stem cell signals for improving sensorimotor and cognitive outcomes after stroke
脑膜干细胞信号可改善中风后的感觉运动和认知结果
- 批准号:
10087979 - 财政年份:2020
- 资助金额:
$ 50.3万 - 项目类别:
Meningeal stem cell signals for improving sensorimotor and cognitive outcomes after stroke
脑膜干细胞信号可改善中风后的感觉运动和认知结果
- 批准号:
10307121 - 财政年份:2020
- 资助金额:
$ 50.3万 - 项目类别:
Meningeal Stem Cell Signals for Improving Sensorimotor and Cognitive Outcomes After Stroke
脑膜干细胞信号可改善中风后的感觉运动和认知结果
- 批准号:
10528477 - 财政年份:2020
- 资助金额:
$ 50.3万 - 项目类别:
Inflammatory Mechanisms of Brain - Lymphatic Signaling in Stroke
脑部炎症机制 - 中风时的淋巴信号传导
- 批准号:
9219104 - 财政年份:2016
- 资助金额:
$ 50.3万 - 项目类别:
Inflammatory Mechanisms of Brain - Lymphatic Signaling in Stroke
脑部炎症机制 - 中风时的淋巴信号传导
- 批准号:
9920224 - 财政年份:2016
- 资助金额:
$ 50.3万 - 项目类别:
Inflammatory Mechanisms of Brain - Lymphatic Signaling in Stroke
脑部炎症机制 - 中风时的淋巴信号传导
- 批准号:
9334323 - 财政年份:2016
- 资助金额:
$ 50.3万 - 项目类别:
Promotion of neurovascular remodeling through mitochondria transfer after stroke
中风后通过线粒体转移促进神经血管重塑
- 批准号:
9272019 - 财政年份:2015
- 资助金额:
$ 50.3万 - 项目类别:
Promotion of neurovascular remodeling through mitochondria transfer after stroke
中风后通过线粒体转移促进神经血管重塑
- 批准号:
9009202 - 财政年份:2015
- 资助金额:
$ 50.3万 - 项目类别:
CD200 as a monocyte/macrophage switch for brain repair after stroke
CD200作为单核细胞/巨噬细胞开关用于中风后的脑修复
- 批准号:
8578114 - 财政年份:2012
- 资助金额:
$ 50.3万 - 项目类别:
相似国自然基金
温度作用下CA砂浆非线性老化蠕变性能的多尺度研究
- 批准号:12302265
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于波动法的叠层橡胶隔震支座老化损伤原位检测及精确评估方法研究
- 批准号:52308322
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
微纳核壳结构填充体系构建及其对聚乳酸阻燃、抗老化、降解和循环的作用机制
- 批准号:52373051
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
东北黑土中农膜源微塑料冻融老化特征及其毒性效应
- 批准号:42377282
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
高层建筑外墙保温材料环境暴露自然老化后飞火点燃机理及模型研究
- 批准号:52376132
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Cause and Effect Relationships Between Glycation and the Ancestry Specific Tumor Stroma
糖化与祖先特异性肿瘤基质之间的因果关系
- 批准号:
10586185 - 财政年份:2023
- 资助金额:
$ 50.3万 - 项目类别:
Telomere Dysfunction as a cause of Chronic Lung Allograft Dysfunction
端粒功能障碍是慢性同种异体肺移植功能障碍的原因
- 批准号:
10772852 - 财政年份:2023
- 资助金额:
$ 50.3万 - 项目类别:
Senescent cells drive mt-DNA accumulation and inflamm-aging
衰老细胞驱动 mt-DNA 积累和炎症衰老
- 批准号:
10816247 - 财政年份:2020
- 资助金额:
$ 50.3万 - 项目类别:
Telomere Dysfunction as a cause of Chronic Lung Allograft Dysfunction
端粒功能障碍是慢性同种异体肺移植功能障碍的原因
- 批准号:
10609432 - 财政年份:2020
- 资助金额:
$ 50.3万 - 项目类别:
Accelerated Aging as a Cause of Chronic Lung Allograft Dysfunction
加速衰老是慢性同种异体肺移植功能障碍的原因
- 批准号:
10662220 - 财政年份:2020
- 资助金额:
$ 50.3万 - 项目类别: